Abstract
Background
Inflammatory and oxidative stress caused by infection has recently been proposed as a mechanism of association between the red cell distribution width (RDW) and infectious diseases, such as community-acquired pneumonia (CAP).
Objective
The present goal was to assess the prognostic importance of the RDW test in patients with CAP.
Patients and methods
The present research was a descriptive and prospective study of patients diagnosed with CAP. All were admitted to Chest Department of Assiut University Hospital between April 2017 and July 2018. Assessment of CAP severity at time of hospital admission using Pneumonia Severity Index was done for all enrolled patients. Complete blood count was measured by automated hematology analyzer, and RDW was reported as a part of the complete blood count result. Normal reference range of RDW was 11.5–14.5%. All of the patients were followed up until being discharged. The outcome variable was in-hospital mortality.
Results
The current study involved 94 patients with CAP: 77 (82%) survived and 17 (18%) died. RDW level was significantly higher in nonsurvivors compared with survivors (18.52±3.07 vs. 12.76±2.08; P=0.022). A significant positive relationship was found between RDW level and Pneumonia Severity Index points (r=0.664; P=0.000). Regarding the diagnostic performance of the RDW test, it was observed that RDW level at cutoff point more than 16.1% had 94.12% sensitivity and 98.70% specificity for the prediction of inhospital mortality in patients with CAP.
Conclusion
The present data indicated that the measurement of RDW on admission may provide the physician with a tool to predict the outcomes of patients with CAP and thus assist in decision making and management in such cases either alone or alongside the other well-established means, taking into account that RDW testing is simple, cheaper, and readily available.
Article PDF
Similar content being viewed by others
Change history
30 October 2020
An amendment to this paper has been published and can be accessed via the original article.
References
Adamuz J, Viasus D, Jimenez-Martinez E, Isla P, Garcia-Vidal C, Dorca J, et al. Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia. J Infect 2014; 68:534–541.
Aziz AOA, Fattah MTA, Mohamed AH, Aziz MOA, Mohammed MS. Mortality predictors in patients with severe community-acquired pneumonia requiring ICU admission. Egypt J Bronchol 2016; 10:155–161.
Ruiz de Oña Lacasta JM, Gómez Fernández M, Celdrán Gil J. Community-acquired pneumonia in inpatients: mortality, comorbidity and risk classes. Rev Clin Esp 2003; 203:64–67.
Varshochi M, Kianmehr P, Naghavi-Behzad M, Bayat-Makoo Z. Correspondence between hospital admission and the pneumonia severity index (PSI), CURB-65 criteria and comparison of their predictive value in mortality and hospital stay. Infez Med 2013; 2:103–110.
Akram AR, Chalmers JD, Hill AT. Predicting mortality with severity assessment tools in out-patients with community-acquired pneumonia. QJM 2011; 104:871–879.
Lam TH, Yau KP. Two unusual cases of severe dysbarism after compressed air work in Hong Kong. Undersea Biomed Res 1984; 11:381–385.
Micek ST, Lang A, Fuller BM, Hampton NB, Kollef MH. Clinical implications for patients treated inappropriately for community-acquired pneumonia in the emergency department. BMC Infect Dis 2014; 14:61.
Li HY, Guo Q, Song WD, Zhou YP, Li M, Chen XK, et al. CUR-65 score for community-acquired pneumonia predicted mortality better than CURB-65 score in low-mortality rate settings. Am J Med Sci 2015; 350:186–190.
Murillo-Zamora E, Medina-González A, Zamora-Pérez L, Vázquez-Yáñez A, Guzmán-Esquivel J, Trujillo-Hernández B. Performance of the PSI and CURB-65 scoring systems in predicting30-day mortality in healthcare-associated pneumonia. Med Clin (Barc) 2018; 150:99–103.
Kim MW, Lim JY, Oh SH. Mortality prediction using serum biomarkers and various clinical risk scales in community-acquired pneumonia. Scand J Clin Lab Invest 2017; 77:486–492.
Hohenthal U, Hurme S, Helenius H, Heiro M, Meurman O, Nikoskelainen J, et al. Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia. Clin Microbiol Infect 2009; 15:1026–1132.
Wang X, Jiao J, Wei R, Feng Y, Ma X, Li Y, et al. A new method to predict hospital mortality in severe community acquired pneumonia. Eur J Intern Med 2017; 40:56–63.
Shaddock EJ. How and when to use common biomarkers in community-acquired pneumonia. Pneumonia (Nathan) 2016; 28:17.
Pierce CN, Larson DF. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 2005; 20:83–90.
Ghaffari S. Oxidative stress in the regulation of normal and neoplastic hematopoiesis. Antioxid Redox Signal 2008; 10:1923–1940.
Lee JH, Chung HJ, Kim K, Jo YH, Rhee JE, Kim YJ, et al. Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia. Am J Emerg Med 2013; 31:72–79.
Braun E, Domany E, Kenig Y, Mazor Y, Makhoul BF, Azzam ZS. Elevated red cell distribution width predicts poor outcome in young patients with community acquired pneumonia. Crit Care 2011; 15:R194.
Braun E, Kheir J, Mashiach T, Naffaa M, Azzam ZS. Is elevated red cell distribution width a prognostic predictor in adult patients with community acquired pneumonia? BMC Infect Dis 2014; 14:129.
Bello S, Fandos S, Lasierra AB, Mincholé E, Panadero C, Simon AL, et al. Red blood cell distribution width [RDW] and long-term mortality after communityacquired pneumonia. A comparison with proadrenomedullin. Respir Med 2015; 109:1193–1206.
Lee SM, Lee JH, Kim K, Jo YH, Lee J, Kim J, et al. The clinical significance of changes in red blood cell distribution width in patients with community-acquired pneumonia. Clin Exp Emerg Med 2016; 3:139–147.
Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352:1011–1023.
Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med 2009; 169:515–523.
Katsoulis K, Kontakiotis T, Baltopoulos G, Kotsovili A, Legakis IN. Total antioxidant status and severity of community-acquired pneumonia: are they correlated? Respiration 2005; 72:381–387.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Yousef, Y.A., Manal, M.A. The relationship between level of the red cell distribution width and the outcomes of patients who acquired pneumonia from community. Egypt J Bronchol 13, 738–742 (2019). https://doi.org/10.4103/ejb.ejb_62_19
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/ejb.ejb_62_19